Main Service/

1st Generation IVF also known as in vitro fertilization-embryo transfer (IVF-ET), aims at infertility due to gynecologic issues, especially those related to the fallopian tubes.
 
In 1978, the first test-tube baby was born in the UK. The cultivation process began with a culture medium in which the sperm would then fertilize the egg naturally (so-called "conventional fertilization"). 1st Generation IVF-ET paved the way for the future development of IVF technology.
Initially, the subjects were women who suffer from fallopian tube blockage. It is posited that the man's sperm is normal, and it would naturally fertilize the egg retrieved in the petri dish. During the culture, the fertilized eggs will divide and then be transplanted into the uterine on the 3rd day or at the stage of blastocyst on the 5th-6th day to continue to grow and develop.
 
However, if the man is also subject to some kind of insufficiency, in vitro fertilization may fail. Therefore, 1st Generation IVF-ET cannot solve infertility caused by factors attributable to the male.

Based on 2nd Generation IVF, 3rd Generation IVF (PGT-A/PGT-M) extracts a small number of trophoblast cells of the fertilized egg at the stage of blastula with a fine needle and conducts molecular diagnosis to check the integrity of the embryos before freezing. The extracted cells will then undergo a molecular genetics test to winnow out embryos that have no chromosomal (PGT-A) or gene (PGT-M) abnormalities for implantation so as to prevent miscarriages due to embryonic chromosomal abnormalities or the possibility of birth of babies with genetic defects.

The standards for assisted reproductive technology adopted by GENE IVF CENTER are even stricter than the international standards. IVF is one of the cutting-edge technologies for infertility treatment.